SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Top Cited Papers
- 14 June 2021
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 397 (10293), 2461-2462
- https://doi.org/10.1016/s0140-6736(21)01358-1
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
This publication has 5 references indexed in Scilit:
- First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in ScotlandNature Medicine, 2021
- Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) DatabaseInternational Journal of Epidemiology, 2021
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ, 2021
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort studyThe Lancet, 2021
- Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national dataBMJ Open, 2020